Aktionärsstruktur

Inhaber in %
Freefloat 71,98
Walgreens Boots Alliance, Inc. 27,61
Vanguard Group, Inc. (Subfiler) 8,54
The Vanguard Group, Inc. 7,53
State Street Corp. 3,54
JPMorgan Investment Management, Inc. 2,83
Boston Partners Global Investors, Inc. 2,43
Vanguard Total Stock Market Index Fund 1,93
BlackRock Fund Advisors 1,91
BlackRock Institutional Trust Co. NA 1,85
Templeton Global Advisors Ltd. 1,74
Vulcan Value Partners LLC 1,66
Vanguard Mid Cap Index Fund 1,63
Vanguard 500 Index Fund 1,47
FIL Investments International 1,45

*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.

Personal

2015 2016 2017 2018 2019
Personal am Ende des Jahres 17.500 19.000 20.000 21.000 22.000
Umsatz pro Mitarbeiter in Mio. EUR 7,77 7,73 7,66 8,00 8,16

Bilanz (in Mio. EUR) - Aktiva

2015 2016 2017 2018 2019
Summe Umlaufvermögen 20.334 22.852 24.303 25.894 28.132
Summe Anlagevermögen 4.127 6.611 5.858 7.595 7.372
Summe Aktiva 27.736 33.656 35.316 38.018 39.460

Bilanz (in Mio. EUR) - Passiva

2015 2016 2017 2018 2019
Gesamtverschuldung/ -verbindlichkeiten 3.493 4.481 3.794 4.662 4.493
Summe Fremdkapital 27.103 31.527 33.252 34.968 36.466
Summe Eigenkapital 634 2.129 2.064 3.050 2.993
Summe Passiva 27.736 33.656 35.316 38.018 39.460

Adresse

1300 Morris Drive, 19087-5594 Chesterbrook
Telefon +1 (610) 727-7000
Internet http://www.amerisourcebergen.com

Management

Bennett S. Murphy
Vice President-Investor Relations
D. Mark Durcan
Independent Director
Dale B. Danilewitz
Chief Information Officer & Executive VP
Dennis M. Nally
Independent Director
Gina K. Clark
Chief Communications & Administration Officer, EVP
Henry Wadsworth McGee
Independent Director
Hyung Bak
Secretary, Vice President & Group General Counsel
Jack F. Quinn
Treasurer & Vice President
James Francis Cleary
Chief Financial Officer & Executive Vice President
Jane Ellen Henney
Lead Independent Director
John G. Chou
Executive VP, Chief Legal Officer & Secretary
Kathleen W. Hyle
Independent Director
Kathy Habecker Gaddes
Chief Compliance Officer & Executive Officer
Lazarus Krikorian
Principal Accounting Officer, SVP & Controller
Leslie E. Donato
Chief Strategy Officer & Executive Vice President
Lon R. Greenberg
Independent Director
Michael J. Long
Independent Director
Ornella Barra
Non-Independent Director
Rafael Augusto Kosa Teixeira
Senior Vice President-Transformation
Richard W. Gochnauer
Independent Director
Robert P. Mauch
EVP & Group President-Pharmaceutical Distribution
Silvana Battaglia
Chief Human Resources Officer & Executive VP
Steven H. Collis
Chairman, President & Chief Executive Officer
Sun Park
Executive Vice President